Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 28


UVB Dependence of Quantum Dot Reactive Oxygen Species Generation in Common Skin Cell Models.

Mortensen LJ, Faulknor R, Ravichandran S, Zheng H, DeLouise LA.

J Biomed Nanotechnol. 2015 Sep;11(9):1644-52.


Susceptibility to quantum dot induced lung inflammation differs widely among the Collaborative Cross founder mouse strains.

Scoville DK, White CC, Botta D, McConnachie LA, Zadworny ME, Schmuck SC, Hu X, Gao X, Yu J, Dills RL, Sheppard L, Delaney MA, Griffith WC, Beyer RP, Zangar RC, Pounds JG, Faustman EM, Kavanagh TJ.

Toxicol Appl Pharmacol. 2015 Dec 1;289(2):240-50. doi: 10.1016/j.taap.2015.09.019. Epub 2015 Oct 21.


miR-98 and its host gene Huwe1 target Caspase-3 in Silica nanoparticles-treated male germ cells.

Xu B, Mao Z, Ji X, Yao M, Chen M, Zhang X, Hang B, Liu Y, Tang W, Tang Q, Xia Y.

Sci Rep. 2015 Aug 11;5:12938. doi: 10.1038/srep12938.


Cell type-dependent changes in CdSe/ZnS quantum dot uptake and toxic endpoints.

Manshian BB, Soenen SJ, Al-Ali A, Brown A, Hondow N, Wills J, Jenkins GJ, Doak SH.

Toxicol Sci. 2015 Apr;144(2):246-58. doi: 10.1093/toxsci/kfv002. Epub 2015 Jan 19.


Nanoparticle exposure in animals can be visualized in the skin and analysed via skin biopsy.

Sykes EA, Dai Q, Tsoi KM, Hwang DM, Chan WC.

Nat Commun. 2014 May 13;5:3796. doi: 10.1038/ncomms4796.


Surface charges and shell crosslinks each play significant roles in mediating degradation, biofouling, cytotoxicity and immunotoxicity for polyphosphoester-based nanoparticles.

Elsabahy M, Zhang S, Zhang F, Deng ZJ, Lim YH, Wang H, Parsamian P, Hammond PT, Wooley KL.

Sci Rep. 2013 Nov 22;3:3313. doi: 10.1038/srep03313.


Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations?

Monteiro-Riviere NA, Samberg ME, Oldenburg SJ, Riviere JE.

Toxicol Lett. 2013 Jul 18;220(3):286-93. doi: 10.1016/j.toxlet.2013.04.022. Epub 2013 May 6.


Cytokines as biomarkers of nanoparticle immunotoxicity.

Elsabahy M, Wooley KL.

Chem Soc Rev. 2013 Jun 21;42(12):5552-76. doi: 10.1039/c3cs60064e. Review.


Microneedle/nanoencapsulation-mediated transdermal delivery: mechanistic insights.

Gomaa YA, Garland MJ, McInnes FJ, Donnelly RF, El-Khordagui LK, Wilson CG.

Eur J Pharm Biopharm. 2014 Feb;86(2):145-55. doi: 10.1016/j.ejpb.2013.01.026. Epub 2013 Feb 24.


Quantification of quantum dot murine skin penetration with UVR barrier impairment.

Mortensen LJ, Jatana S, Gelein R, De Benedetto A, De Mesy Bentley KL, Beck LA, Elder A, Delouise LA.

Nanotoxicology. 2013 Dec;7(8):1386-98. doi: 10.3109/17435390.2012.741726. Epub 2013 Apr 17.


The impact of UVB exposure and differentiation state of primary keratinocytes on their interaction with quantum dots.

Mortensen LJ, Ravichandran S, Delouise LA.

Nanotoxicology. 2013 Nov;7(7):1244-54. doi: 10.3109/17435390.2012.733437. Epub 2012 Oct 25.


Preparation of quantum dot/drug nanoparticle formulations for traceable targeted delivery and therapy.

Yong KT, Wang Y, Roy I, Rui H, Swihart MT, Law WC, Kwak SK, Ye L, Liu J, Mahajan SD, Reynolds JL.

Theranostics. 2012;2(7):681-94. doi: 10.7150/thno.3692. Epub 2012 Jul 27.


Applications of nanotechnology in dermatology.

DeLouise LA.

J Invest Dermatol. 2012 Mar;132(3 Pt 2):964-75. doi: 10.1038/jid.2011.425. Epub 2012 Jan 5. Review.


Modification of microneedles using inkjet printing.

Boehm RD, Miller PR, Hayes SL, Monteiro-Riviere NA, Narayan RJ.

AIP Adv. 2011 Jun;1(2):22139. Epub 2011 Jun 10.


Nanoparticles for transcutaneous vaccination.

Hansen S, Lehr CM.

Microb Biotechnol. 2012 Mar;5(2):156-67. doi: 10.1111/j.1751-7915.2011.00284.x. Epub 2011 Aug 19. Review.


Mitigation of quantum dot cytotoxicity by microencapsulation.

Romoser A, Ritter D, Majitha R, Meissner KE, McShane M, Sayes CM.

PLoS One. 2011;6(7):e22079. doi: 10.1371/journal.pone.0022079. Epub 2011 Jul 21.


Cellular uptake mechanisms and toxicity of quantum dots in dendritic cells.

Zhang LW, Bäumer W, Monteiro-Riviere NA.

Nanomedicine (Lond). 2011 Jul;6(5):777-91. doi: 10.2217/nnm.11.73.


Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery.

Desai P, Patlolla RR, Singh M.

Mol Membr Biol. 2010 Oct;27(7):247-59. doi: 10.3109/09687688.2010.522203. Review.


Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate.

Lopez RF, Seto JE, Blankschtein D, Langer R.

Biomaterials. 2011 Jan;32(3):933-41. doi: 10.1016/j.biomaterials.2010.09.060. Epub 2010 Oct 23.


Naturally occurring nanoparticles from English ivy: an alternative to metal-based nanoparticles for UV protection.

Xia L, Lenaghan SC, Zhang M, Zhang Z, Li Q.

J Nanobiotechnology. 2010 Jun 9;8:12. doi: 10.1186/1477-3155-8-12.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk